NanoViricides, Inc.
NNVC
$1.08
-$0.01-0.92%
AMEX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -34.92% | -22.42% | 39.38% | 47.77% | 118.57% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -43.28% | -11.53% | 17.86% | -5.75% | 55.93% |
| Operating Income | 43.28% | 11.53% | -17.86% | 5.75% | -55.93% |
| Income Before Tax | 42.91% | 11.04% | -19.54% | 4.13% | -58.83% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 42.91% | 11.04% | -19.54% | 4.13% | -58.83% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 42.91% | 11.04% | -19.54% | 4.13% | -58.83% |
| EBIT | 43.28% | 11.53% | -17.86% | 5.75% | -55.93% |
| EBITDA | 44.02% | 11.19% | -19.76% | 6.63% | -61.31% |
| EPS Basic | 54.17% | 32.73% | 12.13% | 22.77% | -35.71% |
| Normalized Basic EPS | 54.18% | 32.67% | 12.09% | 22.67% | -35.71% |
| EPS Diluted | 54.17% | 32.73% | 12.13% | 22.77% | -35.71% |
| Normalized Diluted EPS | 54.18% | 32.67% | 12.09% | 22.67% | -35.71% |
| Average Basic Shares Outstanding | 24.54% | 32.19% | 36.05% | 24.06% | 17.04% |
| Average Diluted Shares Outstanding | 24.54% | 32.19% | 36.05% | 24.06% | 17.04% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |